vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and CVR ENERGY INC (CVI). Click either name above to swap in a different company.
CVR ENERGY INC is the larger business by last-quarter revenue ($2.0B vs $950.5M, roughly 2.1× Astrana Health, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -8.1%, a 8.8% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 20.3%). CVR ENERGY INC produced more free cash flow last quarter ($21.0M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 0.3%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
CVR Energy Inc is a United States-based energy holding company operating two core segments: petroleum refining and nitrogen fertilizer manufacturing. It produces a wide range of products including gasoline, diesel, jet fuel, and agricultural fertilizers, primarily serving commercial, industrial and agricultural customers across North America.
ASTH vs CVI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $2.0B |
| Net Profit | $6.6M | $-160.0M |
| Gross Margin | — | -5.2% |
| Operating Margin | 1.9% | — |
| Net Margin | 0.7% | -8.1% |
| Revenue YoY | 42.9% | 20.3% |
| Net Profit YoY | 184.4% | -56.1% |
| EPS (diluted) | $0.12 | $-1.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.0B | ||
| Q4 25 | $950.5M | $1.8B | ||
| Q3 25 | $956.0M | $1.9B | ||
| Q2 25 | $654.8M | $1.8B | ||
| Q1 25 | $620.4M | $1.6B | ||
| Q4 24 | $665.2M | $1.9B | ||
| Q3 24 | $478.7M | $1.8B | ||
| Q2 24 | $486.3M | $2.0B |
| Q1 26 | — | $-160.0M | ||
| Q4 25 | $6.6M | $-110.0M | ||
| Q3 25 | $373.0K | $374.0M | ||
| Q2 25 | $9.4M | $-114.0M | ||
| Q1 25 | $6.7M | $-123.0M | ||
| Q4 24 | $-7.8M | $28.0M | ||
| Q3 24 | $16.1M | $-124.0M | ||
| Q2 24 | $19.2M | $21.0M |
| Q1 26 | — | -5.2% | ||
| Q4 25 | — | -3.1% | ||
| Q3 25 | — | 28.8% | ||
| Q2 25 | — | -3.7% | ||
| Q1 25 | — | -5.5% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | -3.9% | ||
| Q2 24 | — | 2.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | -5.3% | ||
| Q3 25 | 2.0% | 26.3% | ||
| Q2 25 | 3.1% | -5.8% | ||
| Q1 25 | 3.3% | -8.0% | ||
| Q4 24 | 0.1% | 1.1% | ||
| Q3 24 | 5.9% | -6.2% | ||
| Q2 24 | 6.2% | 1.4% |
| Q1 26 | — | -8.1% | ||
| Q4 25 | 0.7% | -6.1% | ||
| Q3 25 | 0.0% | 19.2% | ||
| Q2 25 | 1.4% | -6.5% | ||
| Q1 25 | 1.1% | -7.5% | ||
| Q4 24 | -1.2% | 1.4% | ||
| Q3 24 | 3.4% | -6.8% | ||
| Q2 24 | 3.9% | 1.1% |
| Q1 26 | — | $-1.91 | ||
| Q4 25 | $0.12 | $-1.09 | ||
| Q3 25 | $0.01 | $3.72 | ||
| Q2 25 | $0.19 | $-1.14 | ||
| Q1 25 | $0.14 | $-1.22 | ||
| Q4 24 | $-0.14 | $0.28 | ||
| Q3 24 | $0.33 | $-1.24 | ||
| Q2 24 | $0.40 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $512.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | — |
| Total Assets | $2.2B | $3.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $512.0M | ||
| Q4 25 | $429.5M | $511.0M | ||
| Q3 25 | $463.4M | $670.0M | ||
| Q2 25 | $342.1M | $596.0M | ||
| Q1 25 | $260.9M | $695.0M | ||
| Q4 24 | $290.8M | $987.0M | ||
| Q3 24 | $350.3M | $534.0M | ||
| Q2 24 | $327.7M | $586.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | $779.3M | $730.0M | ||
| Q3 25 | $775.5M | $840.0M | ||
| Q2 25 | $765.5M | $466.0M | ||
| Q1 25 | $745.4M | $580.0M | ||
| Q4 24 | $712.7M | $703.0M | ||
| Q3 24 | $704.6M | $675.0M | ||
| Q2 24 | $678.9M | $849.0M |
| Q1 26 | — | $3.9B | ||
| Q4 25 | $2.2B | $3.7B | ||
| Q3 25 | $2.2B | $4.0B | ||
| Q2 25 | $1.4B | $4.0B | ||
| Q1 25 | $1.3B | $4.3B | ||
| Q4 24 | $1.4B | $4.3B | ||
| Q3 24 | $1.3B | $3.9B | ||
| Q2 24 | $1.3B | $4.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.40× | ||
| Q3 25 | — | 2.17× | ||
| Q2 25 | — | 3.97× | ||
| Q1 25 | — | 3.29× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 2.33× | ||
| Q2 24 | — | 1.86× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | $21.0M |
| FCF MarginFCF / Revenue | -0.6% | 1.1% |
| Capex IntensityCapex / Revenue | 0.3% | 1.5% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $0 | ||
| Q3 25 | $10.0M | $163.0M | ||
| Q2 25 | $90.9M | $176.0M | ||
| Q1 25 | $16.6M | $-195.0M | ||
| Q4 24 | $-10.9M | $98.0M | ||
| Q3 24 | $34.0M | $48.0M | ||
| Q2 24 | $23.2M | $81.0M |
| Q1 26 | — | $21.0M | ||
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $125.0M | ||
| Q2 25 | $89.5M | $135.0M | ||
| Q1 25 | $13.6M | $-246.0M | ||
| Q4 24 | $-13.5M | $43.0M | ||
| Q3 24 | $31.7M | $14.0M | ||
| Q2 24 | $20.4M | $38.0M |
| Q1 26 | — | 1.1% | ||
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 6.4% | ||
| Q2 25 | 13.7% | 7.7% | ||
| Q1 25 | 2.2% | -14.9% | ||
| Q4 24 | -2.0% | 2.2% | ||
| Q3 24 | 6.6% | 0.8% | ||
| Q2 24 | 4.2% | 1.9% |
| Q1 26 | — | 1.5% | ||
| Q4 25 | 0.3% | 3.0% | ||
| Q3 25 | 0.3% | 2.0% | ||
| Q2 25 | 0.2% | 2.3% | ||
| Q1 25 | 0.5% | 3.1% | ||
| Q4 24 | 0.4% | 2.8% | ||
| Q3 24 | 0.5% | 1.9% | ||
| Q2 24 | 0.6% | 2.2% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 0.44× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | 3.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CVI
Segment breakdown not available.
